[1]
2024. Pathogenetic mechanisms underlying contrast-induced nephropathy in coronary artery disease and type 2 diabetes patients: innovative approaches and future directions. CARDIOLOGY OF UZBEKISTAN. 1, 1 (Mar. 2024), 3–13. DOI:https://doi.org/10.70626/3060-4850-2024-1-1-3-13.